Article citationsMore>>

S. P. Povoski, J. O. Olsen, D. C. Young, J. Clarke, W. E. Burak, M. J. Walker, W. E. Carson, L. D. Yee, D. M. Agnese, R. V. Pozderac, N. C. Hall and W. B. Farrar, “Prospective Randomized Clinical Trial Comparing Intradermal, Intraparenchymal, and Subareolar Injection Routes for Sentinel Lymph Node Mapping and Biopsy in Breast Cancer,” Annals of Surgery Oncology, Vol. 13, No. 11, November 2006, pp. 1412-1421.

has been cited by the following article:

• TITLE: Feasibility of Performing Sentinel Lymph Node Biopsy (SLNB) after Mastectomy: A Case Report

  AUTHORS: Hanadi Bu-Ali, Eleftherios P. Mamouna

  KEYWORDS: Sentinel Lymph Node Biopsy, Lymphatic Mapping, Mastectomy, Lymphoscintigraphy, Axillary Lymph Node Dissection

  JOURNAL NAME: Journal of Cancer Therapy, Vol.1 No.2, June 29, 2010

  ABSTRACT: Introduction: Previous mastectomy remains a contraindication to SLNB as normal drainage patterns of the breast can be disturbed. Patients diagnosed with DCIS on core biopsy and later found to have microinvasive or invasive carci-noma at the time of mastectomy are deprived of the opportunity for SLNB and need to undergo axillary dissection. We explored the option and feasibility of performing SLNB in a 39-year-old female who underwent a simple mastectomy without axillary sampling for extensive DCIS and later found to have microinvasive ductal carcinoma on permanent pathology. Results: Lymphatic mapping using subdermal injection of 99mTc-labeled sulfur colloid and blue dye led to the identification of five SLNs. Histopathologic examination showed no metastasis. Conclusion: SNLB is feasible in this setting. However, before its use is routinely adopted, its feasibility and accuracy has to be demonstrated in larger num-bers of patients in whom a negative SLNB is followed by a completion axillary dissection.